Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 7:10:1189-95.
doi: 10.2147/PPA.S100844. eCollection 2016.

A renewed Medication Adherence Alliance call to action: harnessing momentum to address medication nonadherence in the United States

Leah L Zullig  1 , Bradi B Granger  2 , Hayden B Bosworth  3
Affiliations

A renewed Medication Adherence Alliance call to action: harnessing momentum to address medication nonadherence in the United States

Leah L Zullig et al. Patient Prefer Adherence. .

Abstract

The problem: Nonadherence to prescription medications is a common and costly problem with multiple contributing factors, spanning the dimensions of individual behavior change, psychology, medicine, and health policy, among others. Addressing the problem of medication nonadherence requires strategic input from key experts in a number of fields.

Meeting of experts: The Medication Adherence Alliance is a group of key experts, predominately from the US, in the field of medication nonadherence. Members include representatives from consumer advocacy groups, community health providers, nonprofit groups, the academic community, decision-making government officials, and industry. In 2015, the Medication Adherence Alliance convened to review the current landscape of medication adherence. The group then established three working groups that will develop recommendations for shifting toward solutions-oriented science.

Commentary of expert opinion: From the perspective of the Medication Adherence Alliance, the objective of this commentary is to describe changes in the US landscape of medication adherence, framing the evolving field in the context of a recent think tank meeting of experts in the field of medication adherence.

Keywords: chronic disease; health planning recommendations; medication adherence.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Institute of Medicine . Informing the Future: Critical Issues in Health. Washington, DC: National Academies Press; 2007. Pharmaceuticals: the good and the bad; p. 13.
    1. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–314. - PMC - PubMed
    1. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028–3035. - PubMed
    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. - PubMed
    1. Aitken M, Valkova S. Avoidable Costs in US Healthcare: The $200 Billion Opportunity from Using Medicines More Responsibly. Parsip-pany, NJ: IMS Institute for Healthcare Informatics; 2013.